Sandoz Slams Big Pharma Call for Higher Drug Prices in Europe

Swiss generic-drug maker Sandoz Group AG sharply criticized a recent appeal by Europe’s pharmaceutical industry urging the European Union to increase drug prices as a way to counter the threat of US tariffs.

“When we talk about the need for US prices to fall, it’s certainly not European patients who should be paying more as a result,” said Sandoz Chief Executive Officer Richard Saynor in an interview with Swiss newspaper Aargauer Zeitung published on Saturday.

“That is a highly questionable proposal,” Saynor said. “How could European governments ever consider it? It defies all logic.”

Novartis AG CEO Vas Narasimhan and ...